JP2006512077A5 - - Google Patents

Download PDF

Info

Publication number
JP2006512077A5
JP2006512077A5 JP2004564004A JP2004564004A JP2006512077A5 JP 2006512077 A5 JP2006512077 A5 JP 2006512077A5 JP 2004564004 A JP2004564004 A JP 2004564004A JP 2004564004 A JP2004564004 A JP 2004564004A JP 2006512077 A5 JP2006512077 A5 JP 2006512077A5
Authority
JP
Japan
Prior art keywords
hcv
cell
test compound
absence
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004564004A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006512077A (ja
Filing date
Publication date
Priority claimed from US10/328,997 external-priority patent/US20030232745A1/en
Application filed filed Critical
Publication of JP2006512077A publication Critical patent/JP2006512077A/ja
Publication of JP2006512077A5 publication Critical patent/JP2006512077A5/ja
Withdrawn legal-status Critical Current

Links

JP2004564004A 2002-12-24 2003-12-22 Ｃ型肝炎ウイルスの感染を阻害するための、ｄｃ−ｓｉｇｎおよびｄｃ−ｓｉｇｎｒの使用 Withdrawn JP2006512077A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/328,997 US20030232745A1 (en) 2001-06-26 2002-12-24 Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection
PCT/US2003/041093 WO2004058953A1 (en) 2002-12-24 2003-12-22 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection

Publications (2)

Publication Number Publication Date
JP2006512077A JP2006512077A (ja) 2006-04-13
JP2006512077A5 true JP2006512077A5 (https=) 2007-02-15

Family

ID=32680776

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004564004A Withdrawn JP2006512077A (ja) 2002-12-24 2003-12-22 Ｃ型肝炎ウイルスの感染を阻害するための、ｄｃ−ｓｉｇｎおよびｄｃ−ｓｉｇｎｒの使用

Country Status (6)

Country Link
US (1) US20030232745A1 (https=)
EP (1) EP1583824A4 (https=)
JP (1) JP2006512077A (https=)
AU (1) AU2003299856A1 (https=)
CA (1) CA2511243A1 (https=)
WO (1) WO2004058953A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1046651A1 (en) 1999-04-19 2000-10-25 Koninklijke Universiteit Nijmegen Composition and method for modulating dendritic cell-T interaction
US7022323B2 (en) * 2001-06-26 2006-04-04 Progenics Pharmaceuticals, Inc. Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
AU2003269389A1 (en) * 2002-09-20 2004-04-08 Stichting Katholieke Universiteit Antigen uptake receptor for candida albicans on dendritic cells
US7691591B2 (en) * 2002-09-20 2010-04-06 Stichting Katholieke Universiteit Methods of identifying and isolating cells expressing DC-sign
JP2008504222A (ja) * 2003-12-15 2008-02-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド 新規の抗ｄｃ−ｓｉｇｎ抗体
ATE474587T1 (de) * 2004-09-29 2010-08-15 Univ Tulane Inhibitoren des hepatitis-c-virus
EP1976596B1 (en) * 2005-12-01 2013-07-31 Government Of The United States Of America, As Represented By The Secretary, Department of Health Human Services Anti-viral griffithsin compounds, compositions, and methods of use
JPWO2013069749A1 (ja) * 2011-11-10 2015-04-02 興和株式会社 生物由来の生理活性物質の測定方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US300971A (en) * 1884-06-24 Carriage-top
US184150A (en) * 1876-11-07 Improvement in cultivating-harrows
US5679342A (en) * 1987-11-18 1997-10-21 Chiron Corporation Hepatitis C virus infected cell systems
EP0842947B2 (en) * 1990-11-08 2009-03-18 Novartis Vaccines and Diagnostics, Inc. Hepatitis C virus asialoglycoproteins
ZA927837B (en) * 1991-10-15 1994-03-11 Akzo Nv Monoclonal antibodiesto hepatitis C virus
US6391567B1 (en) * 2000-03-02 2002-05-21 New York University Identifying compounds inhibiting DC-sign facilitation of HIV into cells

Similar Documents

Publication Publication Date Title
Chevaliez Virological tools to diagnose and monitor hepatitis C virus infection
ES2895262T3 (es) Cuantificación del genoma de anelovirus como biomarcador de la inmunosupresión
Erensoy Diagnosis of hepatitis C virus (HCV) infection and laboratory monitoring of its therapy
Hapaurachchi et al. Laboratory confirmation of dengue and chikungunya co-infection
JP2013505007A5 (https=)
JP2006512077A5 (https=)
WO2003089929A1 (en) Device, method, and kit for gene detection
KR20200083444A (ko) 호흡기 세포융합 바이러스 종의 니킹 및 연장 증폭 반응(near)
WO1991011534A1 (en) A rapid and sensitive test for detecting hepatitis a virus
Klepper et al. Hepatitis C virus double‐stranded RNA is the predominant form in human liver and in interferon‐treated cells
KR20230007464A (ko) 호흡기 병원체 검출을 위한 검체수송 키트 및 이를 이용한 호흡기 병원체 검출방법
CN104212914B (zh) 埃博拉五重荧光pcr快速超敏检测试剂盒及其应用
Elkady et al. Performance of two Real‐Time RT‐PCR assays for quantitation of hepatitis C virus RNA: Evaluation on HCV genotypes 1–4
US20240271229A1 (en) Reagents and Methods for Detecting HCV
EP4168570A1 (en) Method for detecting the presence of coronavirus nucleic acid
Rho et al. Hepatitis C virus (HCV) genotyping by annealing reverse transcription-PCR products with genotype-specific capture probes
JP2000325099A (ja) 新規な核酸ハイブリダイゼーション用緩衝溶液
Legler et al. Specific magnetic bead-based capture of free fetal DNA from maternal plasma
US20080125333A1 (en) Devices and kits for detecting one or more target agents
CN102344970A (zh) 同时检测人cmv和bk病毒dna的引物序列及定量检测试剂盒
Fabrizi et al. Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients
Chomean et al. Quartz crystal microbalance-based biosensor for the detection of α-thalassemia 1 (SEA deletion).
Mukaide et al. New combination test for hepatitis C virus genotype and viral load determination using Amplicor GT HCV MONITOR test v2. 0
JP2006525351A5 (https=)
US20110104300A1 (en) Methods for Screening Chemical, Biological, and Physical Agents for Disinfecting Infectious Norovirus